All stock lists
BioStem Technologies, Inc. (NASDAQ:BSEM)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.57-0.09 (-5.42%)
Insider Score
––Not scored
BSEM Insider Score
Insiders here have filed 17 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BSEM analyst forecast
BSEM analyst consensus
No analyst ratings in the last 3 months.
BSEM 12-month price target
$7.00+364.8% upsideaverage of 1 firm
$7.00High
$7.00Low
Best analysts covering BSEM
No firm covering BSEM has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BSEM analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| H.C. Wainwright | — | $7.00 | +97.7% | — | 2026-08-24 | |
| H.C. Wainwright | — | $9.00 | +113.6% | — | 2026-05-06 |
BSEM earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-24 | 0.02 | -0.67 | $55.2M | $10.1M |
| 2026-05-14 | -0.28 | -0.52 | $5.7M | $6.1M |
| 2026-08-12 | -0.50 | -0.52 | $6.4M | $7.9M |
| 2026-11-12 | -0.43 | 0.00 | $7.2M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.